GLAXO SMITH KLINE

Lobbying Spend

—

Filings

Firms Hired

Active Period

1999–2004

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2004	—	2	1
2003	—	2	2
2002	—	3	2
2001	—	2	1
2000	—	5	2
1999	—	4	2

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BERGNER BOCKORNY CASTAGNETTI HAWKINS & BRAIN	—	8
SKADDEN, ARPS, SLATE, MEAGHER & FLOM (UK) LLP	—	10

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	13
SENATE	13
Environmental Protection Agency (EPA)	4
State, Dept of (DOS)	4
Food & Drug Administration (FDA)	3
U.S. Trade Representative (USTR)	2
Executive Office of the President (EOP)	1
White House Office	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	8
Pharmacy	Pharmacy	8
Medicare/Medicaid	Medicare/Medicaid	8
Health Issues	Health Issues	6
Trade (domestic/foreign)	Trade (domestic/foreign)	5
Environment/Superfund	Environment/Superfund	2

GLAXO SMITH KLINE — Lobbying Disclosure | Poliscope